Trial · NCT02699515
Adverse events2,744
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,744
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Expansion Cohort: Biliary Tract Cancer | 10 | 30 | 15 |
| other | Anaemia | Blood and lymphatic system disorders | Expansion Cohort: Gastric Cancer (GC) | 11 | 31 | 16 |
| other | Anaemia | Blood and lymphatic system disorders | Expansion Cohort: Esophageal Squamous Cell Cancer | 7 | 30 | 11 |
| other | Anaemia | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (3 mg/kg) | 3 | 4 | 3 |
| other | Anaemia | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (10 mg/kg) | 0 | 3 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (20 mg/kg) | 2 | 7 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Expansion Cohort: Hepatocellular Carcinoma (3 mg/kg) | 0 | 3 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Expansion Cohort: Hepatocellular Carcinoma (10 mg/kg) | 1 | 6 | 1 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Expansion Cohort: Biliary Tract Cancer | 0 | 30 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Expansion Cohort: Gastric Cancer (GC) | 1 | 31 | 1 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Expansion Cohort: Esophageal Squamous Cell Cancer | 0 | 30 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (3 mg/kg) | 0 | 4 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (10 mg/kg) | 0 | 3 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (20 mg/kg) | 0 | 7 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Expansion Cohort: Hepatocellular Carcinoma (3 mg/kg) | 0 | 3 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Expansion Cohort: Hepatocellular Carcinoma (10 mg/kg) | 0 | 6 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Expansion Cohort: Biliary Tract Cancer | 0 | 30 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Expansion Cohort: Gastric Cancer (GC) | 0 | 31 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Expansion Cohort: Esophageal Squamous Cell Cancer | 1 | 30 | 1 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Dose Escalation Cohort: M7824 (3 mg/kg) | 0 | 4 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02699515/events